Several months ago, a major battle began in corporate
ophthalmology that may (or may not)
profoundly affect our profession and our patients.
A blue chip ophthalmic company, Allergan,
became the target of a hostile takeover by Valeant
Pharmace…
Month: July 2014
Focal choroidal excavation’s coexistence with other choroidal diseases impairs vision
Focal choroidal excavation appears to be relatively common and can have a detrimental effect on vision, a study of Korean patients suggests.
Reticular drusen linked to AMD progression
Four percent of individuals aged 49 years and above will develop reticular drusen over 15 years of follow-up, Australian study findings suggest, with the incidence higher in those with age-related macular degeneration risk factors.
Vitreous anatomic features characterised
Researchers have found a direct anteroposterior connection between the retrolental and premacular and preoptic spaces that exits in young adults before the occurrence of vitreous degeneration.
SD-OCT a valuable assessment tool for corneal epithelial thickness after cataract surgery
Spectral-domain optical coherence tomography of epithelial remodeling after cataract removal showed corneal and epithelial thickness returned to baseline by 4 weeks postoperatively, according to a study.The observational, prospective, longitudinal stud…
A 32-Year-Old Woman With Decreased Vision in Her Left Eye
A 32-year-old woman with a known brain tumor has decreased vision in her left eye. What is your differential diagnosis? Medscape Ophthalmology
No Change in Retinopathy in Diabetes 2 Years After Surgery
Two years after diabetic patients undergo bariatric surgery, diabetic retinopathy has neither worsened nor improved, data from STAMPEDE show. Regular eye exams are still important, investigators stress. Medscape Medical News
AAO reiterates cannabis not recommended for glaucoma treatment
The American Academy of Ophthalmology is reminding ophthalmologists and the public that it does not recommend marijuana or other cannabis products for the treatment of glaucoma, according to a press release.The Academy also reported that, based on an a…
CooperVision to acquire Sauflon
The Cooper Companies Inc. announced Monday that it has reached an agreement to acquire Sauflon Pharmaceuticals Ltd.As detailed in the release from Cooper, the purchase, valued at about $1.2 billion, is expected to close by the end of the fiscal year on…
Repeat-Use Procedure for Iluvien receives positive outcome in 10 European countries
Alimera Sciences has announced a positive outcome for its Repeat-Use Procedure for Illuvien, a treatment for diabetic macular edema, in an additional 10 European countries, according to a company press release.As part of the regulatory process, the com…
BioLight enrolls first patient in FDA Phase 1/2a clinical trial with Eye-D for treatment of glaucoma
BioLight Israeli Life Sciences Investments Ltd., a firm that invests in, manages and commercializes biomedical innovations grouped into clusters around defined medical conditions, announces that the first patient has been enrolled in the U.S. into a FD…